EUVIMEDEUVIMED entdecken
Crossref

tPLGA nanoparticles combined with CCL2/CCR2 inhibitor mitigate post-thrombolytic hemorrhagic transformation

Feiyang Luo, Jingmei Pan, Zhenhua Wang, Che Qing, Xi Xiao, Xing Guo, Shaobing Zhou

Biomaterials Science · 2026 · 14 (5) · 1249-1261

DOI: 10.1039/d5bm01807b ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Feiyang Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu 610031, P. R. China. xingguo@swjtu.edu.cn. Hauptthemen laut MEDLINE: Chemokine CCL2, Nanoparticles, Tissue Plasminogen Activator, Receptors, CCR2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program, Southwest Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An MMP-9-responsive tPLGA nanoplatform enables spatiotemporally controlled tPA delivery for targeted thrombolysis. Coupling with CCL2/CCR2 inhibition suppresses neuroinflammation, preserves BBB integrity, and prevents hemorrhagic transformation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CCL2NanoparticlesTissue Plasminogen ActivatorReceptors, CCR2OxadiazolesAnimalsMicePolylactic Acid-Polyglycolic Acid CopolymerBlood-Brain BarrierMaleMatrix Metalloproteinase 9Drug CarriersMice, Inbred C57BLIndazolesPropionates

Substanzen

Chemokine CCL2Tissue Plasminogen ActivatorReceptors, CCR2Polylactic Acid-Polyglycolic Acid CopolymerbindaritOxadiazolesMatrix Metalloproteinase 9Ccr2 protein, mouseCcl2 protein, mouseDrug Carriers

Autor:innen und Institutionen

  • Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University, Chengdu 610031, P. R. China. xingguo@swjtu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Sichuan Province Science and Technology Support Program
  • Southwest Jiaotong University
  • National Key Research and Development Program of China

Zitieren

APA

Luo, F., Pan, J., Wang, Z., Qing, C., Xiao, X., Guo, X., & Zhou, S. (2026). tPLGA nanoparticles combined with CCL2/CCR2 inhibitor mitigate post-thrombolytic hemorrhagic transformation. Biomaterials Science, 14(5), 1249-1261. https://doi.org/10.1039/d5bm01807b

Vancouver

Luo F, Pan J, Wang Z, Qing C, Xiao X, Guo X, et al. tPLGA nanoparticles combined with CCL2/CCR2 inhibitor mitigate post-thrombolytic hemorrhagic transformation. Biomaterials Science. 2026;14(5):1249-1261. doi:10.1039/d5bm01807b

BibTeX
@article{Luo2026,
  author = {Luo, Feiyang and Pan, Jingmei and Wang, Zhenhua and Qing, Che and Xiao, Xi and Guo, Xing and Zhou, Shaobing},
  title = {tPLGA nanoparticles combined with CCL2/CCR2 inhibitor mitigate post-thrombolytic hemorrhagic transformation},
  journal = {Biomaterials Science},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {1249--1261},
  doi = {10.1039/d5bm01807b}
}
Kostenlos starten →